Killam A L, Watts S W, Cohen M L
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA.
Eur J Pharmacol. 1995 Jan 24;273(1-2):7-14. doi: 10.1016/0014-2999(94)00613-c.
Urinary obstruction from benign prostatic hyperplasia is a common clinical problem possibly associated with excessive prostatic constriction around the urethra. These studies compared adrenergic and serotonergic functional activity to specific alpha 1 and serotonin (5-hydroxytryptamine; 5-HT) binding sites in the rat prostate. Isolated, left ventral lobes of the rat prostate were removed and examined for in vitro contraction. Norepinephrine-induced contraction of the rat prostate was competitively blocked by prazosin with an apparent antagonist dissociation constant (pKB) of 8.13. 5-HT also contracted the rat prostate. However, in the presence of prazosin, maximum 5-HT contraction was reduced by half suggesting that high concentrations of 5-HT can activate alpha 1 receptors in the prostate. The concentration-response curve to 5-HT in the presence of 1 microM prazosin was competitively inhibited by the 5-HT2 receptor antagonist LY53857 (6-methyl-1-(1-methylethyl)ergoline-8-carboxylic acid 2-hydroxyl-1-methylpropylester (Z)-2-butenedioate (1:1)) (pKB = 9.02). Autoradiographic studies with [125I]LSD (2-iodo-lysergic acid diethylamide) documented the presence of 5-HT2 receptors since significant displacement of the radioligand occurred with 5-HT and LY53857, but not with prazosin. The alpha 1-adrenoceptor ligand [125I]HEAT ([beta-(4-hydroxy-3-iodophenyl)ethylaminomethyl]-tetralone) confirmed the presence of alpha 1-adrenoceptors in the rat prostate since significant displacement of the radioligand occurred with prazosin, but not 5-HT or LY53857. The inability of prazosin to displace [125I]LSD and the inability of 5-HT to displace [125I]HEAT suggest that 5-HT cannot directly interact with alpha 1-adrenoceptors in the prostate.(ABSTRACT TRUNCATED AT 250 WORDS)
良性前列腺增生引起的尿路梗阻是一个常见的临床问题,可能与尿道周围前列腺过度收缩有关。这些研究比较了大鼠前列腺中肾上腺素能和血清素能功能活性与特定的α1和血清素(5-羟色胺;5-HT)结合位点。切除大鼠前列腺的孤立左叶腹侧,进行体外收缩检测。去甲肾上腺素诱导的大鼠前列腺收缩被哌唑嗪竞争性阻断,表观拮抗剂解离常数(pKB)为8.13。5-HT也能使大鼠前列腺收缩。然而,在哌唑嗪存在的情况下,5-HT的最大收缩幅度减半,这表明高浓度的5-HT可激活前列腺中的α1受体。在1 microM哌唑嗪存在的情况下,5-HT的浓度-反应曲线被5-HT2受体拮抗剂LY53857(6-甲基-1-(1-甲基乙基)麦角林-8-羧酸2-羟基-1-甲基丙酯(Z)-2-丁烯二酸酯(1:1))竞争性抑制(pKB = 9.02)。用[125I]LSD(2-碘-麦角酸二乙酰胺)进行的放射自显影研究证明了5-HT2受体的存在,因为放射性配体可被5-HT和LY53857显著取代,但不能被哌唑嗪取代。α1-肾上腺素能受体配体[125I]HEAT([β-(4-羟基-3-碘苯基)乙胺甲基]-四氢萘酮)证实了大鼠前列腺中α1-肾上腺素能受体的存在,因为放射性配体可被哌唑嗪显著取代,但不能被5-HT或LY53857取代。哌唑嗪不能取代[125I]LSD以及5-HT不能取代[125I]HEAT表明5-HT不能直接与前列腺中的α1-肾上腺素能受体相互作用。(摘要截短于250字)